Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-11 @ 9:09 PM
Study NCT ID:
NCT02704858
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2016-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Sponsor:
Neonc Technologies, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NEO100-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None